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Current Status of 
Avian/Pandemic Influenza 
The current pandemic alert phase is still at alert 
level 3 where a new influenza viral subtype is causing 
disease in humans but is not yet spreading efficiently 
and sustainable among humans. 
20 human cases of infection with the 
highly pathogenic avian influenza in 
Turkey have been con finned (3 have 
died). 18 of them were children between 
4-18 years of age. Althcugh virology 
sampling shows that the H5N I virus is 
the same as in East Asia, Turkey is seeing 
a fatality rate of20%, which is lower 
than the fatality rate observed in Asia, 
which is around 58%. 
There has also been a 5th cluster of 
cases in Indonesia. 20 cases and 13 
deaths have been reported in this country. 
Evidence indicates that patients acquired 
infection following close contact with 
infected poUltry. 
Syria and Iran have destroyed 
thousands of birds to create a buffer 
against the spread of the bird flu. 
Outbreaks of avian influenza in birds 
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are also occurring in Romania, Ukraine, 
Russia and China. There was a suspected 
human avian case in Iraq on the 18th 
January 2006. 
In Japan, the H5N2 strain has been 
found in poultry. This is a low pathogenic 
avian influenza. A number of poUltry 
workers have also been found to be 
seropositive to this virus. 
On the 14th January 2006, the US 
Centers for Disease Control and 
Prevention (CDC) announced that two 
drugs typically prescribed to fight the 
virus will be ineffective this season and 
should not be prescribed. The CDC 
found that amantadine and rimantadine 
were ineffective 91 % of the time against 
H3N2 influenza, the dominant strain this 
season. Resistance to amantadine and 
rimantadine has been climbing in recent 
years, particularly in Asia. There has 
been a huge leap this year (2006) in the 
United States for reasons that are still 
unclear. In fact, 2 years ago, 2% of 
circulating flu viruses were resistant to 
the 2 drugs. During the last flu season, 
11 % were resistant. This season, 91 % 
of virus samples tested have been found 
to be resistant. However, 2 other antiviral 
drugs, Tamiflu® (oseltamivir) and 
Relenza® (zanamivir) are still effective. 
Following a recent article in the New 
England Journal of Medicine, senior 
World Health Organization Officials 
have stated that some resistance to 
Tamiflu® is inevitable as this is 
expected to happen with usage of 
antibiotics and antivirals. However this 
is not alarming. More research is needed 
to understand whether the dosage 
regime is contributing towards 
resistance. Tamiflu® still remains an 
'excellent choice' among the limited 
antivirals available against the HSNl 
virus. 8J 
(More regular free updates on the 
Avian/Pandemic Influenza can be 
accessed on the TheSYNAPSE Web 
Portal on http://www.thesynapse.netl) 
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